Myogenica, Inc.
PrivateLast Round
Grant
Apr 1, 2024
Total Funding Raised
$600,000
Company Overview
Myogenica, Inc. is a biotechnology company that develops induced pluripotent stem cell-derived muscle stem cell therapies for the treatment of muscular dystrophy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Myogenica, Inc. Comparables
Compare Myogenica, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MyoPax | 83% | |
| Vita Therapeutics | 83% | |
| IPS HEART | 81% | |
Myogenica, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 1, 2024 | ||||
| Seed | Mar 22, 2022 |
Myogenica, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Parent Project Muscular Dystrophy | Grant |
| Duchenne UK | Grant |
| SeedFolio | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2024
$500K raised from Duchenne UK and Parent Project Muscular Dystrophy.
Myogenica, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Myogenica, Inc.'s valuation, stock price, and market status.